L-arginine

Generic Name: L-arginine

Brand Names: Clinimix 2.75/5

Drug Type: Small Molecule

Chemical Formula: -

CAS Number: 74-79-3

Unique Ingredient Identifier: -

Associated Conditions: -

Associated Therapies: -

Clinical Trials

L-Arginine and Sickle Cell Disease

Phase 3

Completed

Conditions: Sickle Cell Disease

Interventions: Drug: L-arginine
Drug: Placebo

First Posted Date: 2010-06-11

Last Posted Date: 2010-06-11

Lead Sponsor: Hospital de Clinicas de Porto Alegre

Target Recruit Count: 40

Registration Number: NCT01142219

Locations: 🇧🇷
Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil

Directed Immuno Nutrition by L-arginine for Critically Ill Patients

Phase 4

Completed

Conditions: Critically Ill

Interventions: Drug: L-arginine
Drug: placebo

First Posted Date: 2009-12-24

Last Posted Date: 2013-09-18

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 30

Registration Number: NCT01038622

Locations: 🇫🇷
Medical Intensive Care Unit, Pompidou Hospital, Paris, France

L-arginine Effects on Chronic Hypertension in Pregnancy

Phase 3

Completed

Conditions: Hypertension in Pregnancy

Interventions: Other: placebo
Drug: L-arginine

First Posted Date: 2009-09-10

Last Posted Date: 2010-01-20

Lead Sponsor: University of Modena and Reggio Emilia

Target Recruit Count: 80

Registration Number: NCT00974714

Locations: 🇮🇹
University of Modena and Reggio Emilia, Modena, Mo, Italy

Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome

Phase 3

Completed

Conditions: Metabolic Syndrome
Impaired Glucose Tolerance
Insulin Resistance
Endothelial Dysfunction

Interventions: Drug: Placebo
Drug: L-arginine

First Posted Date: 2009-06-10

Last Posted Date: 2009-06-10

Lead Sponsor: IRCCS San Raffaele

Target Recruit Count: 142

Registration Number: NCT00917449

Locations: 🇮🇹
Scientific Institute San Raffaele, Milan, Italy

Endothelial Function in Human Arteries

Early Phase 1

Completed

Conditions: Endothelial Dysfunction

Interventions: Drug: L-arginine

First Posted Date: 2009-02-20

Last Posted Date: 2017-03-07

Lead Sponsor: The Cleveland Clinic

Target Recruit Count: 25

Registration Number: NCT00848302

L-Arginine and Erectile Dysfunction

Phase 4

Completed

Conditions: Erectile Dysfunction

Interventions: Drug: Placebo
Drug: L-arginine

First Posted Date: 2008-10-22

Last Posted Date: 2008-10-22

Lead Sponsor: Hannover Medical School

Target Recruit Count: 57

Registration Number: NCT00777075

Locations: 🇩🇪
Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Lower Saxony, Germany

L-arginine in Treatment as Usual in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Drug: L-Arginine

First Posted Date: 2008-07-18

Last Posted Date: 2017-09-05

Lead Sponsor: University of Alberta

Target Recruit Count: 13

Registration Number: NCT00718510

Locations: 🇨🇦
Alberta Hospital Edmonton, Edmonton, Alberta, Canada

L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)

Phase 3

Completed

Conditions: Smear Positive Pulmonary Tuberculosis

Interventions: Drug: L-arginine
Drug: Vitamin D
Drug: Placebo L-arginine
Drug: Placebo Vitamin D

First Posted Date: 2008-05-14

Last Posted Date: 2012-01-18

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 200

Registration Number: NCT00677339

Locations: 🇮🇩
Timika Tuberculosis Clinic and Community Hospital, Timika, Papua Province, Indonesia

Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria

Phase 2

Suspended

Conditions: Severe Falciparum Malaria

Interventions: Other: Normal saline
Drug: L-arginine hydrochloride

First Posted Date: 2008-02-15

Last Posted Date: 2024-03-13

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 8

Registration Number: NCT00616304

Locations: 🇮🇩
Mitra Masyarakat Hospital, Timika, Papua, Indonesia

Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling

Not Applicable

Completed

Conditions: Cardiovascular Diseases

Interventions: Drug: Phenylephrine
Drug: L-NAME
Drug: L-Arginine

First Posted Date: 2008-01-29

Last Posted Date: 2018-09-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 54

Registration Number: NCT00603720

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy